A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy
暂无分享,去创建一个
F. Schittulli | G. Colucci | E. Maiello | C. Rella | M. Coviello | F. Giotta | Paolo Colavito | D. Colangelo | M. Quaranta
[1] D. Yeshurun,et al. Thromboembolism in cancer. Changing trends , 1993, Cancer.
[2] J. V. Sørensen,et al. Venous thromboembolism and cancer. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[3] S. Dawson,et al. The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review. , 1992, Atherosclerosis.
[4] R. Gray,et al. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] D. Carney,et al. Thromboembolism. A complication of weekly chemotherapy in the treatment of non‐Hodgkin's lymphoma , 1990, Cancer.
[6] R. Ádány,et al. Factors of the Extrinsic Pathway of Blood Coagulation in Tumour Associated Macrophages , 1989, Thrombosis and Haemostasis.
[7] L. Norton,et al. Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study. , 1989, The American journal of medicine.
[8] S. Feffer,et al. Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5‐fluorouracil , 1989, Cancer.
[9] C. Redmond,et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. , 1989, The New England journal of medicine.
[10] P. Callas,et al. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. , 1989, Blood.
[11] M. Auger,et al. Effects of tamoxifen on blood coagulation , 1988, Cancer.
[12] J. Hirsh,et al. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. , 1988, The New England journal of medicine.
[13] F. Cozzolino,et al. Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia. , 1988, The American journal of medicine.
[14] J. Fontana,et al. Chemotherapy for breast cancer decreases plasma protein C and protein S. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] R. Fisher,et al. Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] H. Dvorak. Thrombosis and cancer. , 1987, Human pathology.
[17] P. Bruzzi,et al. Hypercoagulable state induced by cytostatic drugs in stage ii breast cancer patients , 1986, Cancer.
[18] A. Falanga,et al. Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. , 1985, Biochemistry.
[19] R. M. Vazquez,et al. Thromboembolic complications associated with L‐asparaginase therapy. Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma , 1985, Cancer.
[20] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.
[21] C. Esmon,et al. Familial protein S deficiency is associated with recurrent thrombosis. , 1984, The Journal of clinical investigation.
[22] T. Barbui,et al. L-Asparaginase Lowers Protein C Antigen , 1984, Thrombosis and Haemostasis.
[23] H. Saito,et al. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five‐drug chemotherapy regimen , 1984, Cancer.
[24] R. Enck,et al. Tamoxifen treatment of metastatic breast cancer and antithrombin III levels , 1984, Cancer.
[25] J. Griffin,et al. Plasma protein S deficiency in familial thrombotic disease. , 1984, Blood.
[26] F. Rickles,et al. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. , 1983, Blood.
[27] F. Rickles,et al. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. , 1981, The Journal of laboratory and clinical medicine.
[28] J. Griffin,et al. Deficiency of protein C in congenital thrombotic disease. , 1981, The Journal of clinical investigation.
[29] R. Weiss,et al. Venous thrombosis during multimodal treatment of primary breast carcinoma. , 1981, Cancer treatment reports.
[30] E. Vellenga,et al. ANTITHROMBIN III DEFICIENCY DURING ASPARAGINASE THERAPY , 1980, The Lancet.
[31] R L Bick,et al. Alterations of Hemostasis Associated With Malignancy: Etiology, Pathophysiology, Diagnosis and Management , 2008, Seminars in thrombosis and hemostasis.
[32] A. Clauss,et al. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .
[33] A. Clauss. [Rapid physiological coagulation method in determination of fibrinogen]. , 1957, Acta haematologica.
[34] N. Fowler. Thromboembolism , 1950 .
[35] A. Trousseau. Phlegmasia alba dolens. , 1865 .